Evidence map›Paper›PMID 12719578›Full record

ArticleJournal of virology2003

In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Andreas Jekle, Oliver T Keppler, Erik De Clercq, Dominique Schols, Mark Weinstein, Mark A Goldsmith

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. HIV infection.Nature reviews. Disease primers · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Andreas JekleGladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California 94141-9100, USA. ajekle@gladstone.ucsf.edu
Oliver T Keppler
Erik De Clercq
Dominique Schols
Mark Weinstein
Mark A Goldsmith
Institute of Virology of the Slovak Academy of Sciences · SKRega Institute for Medical Research · BEUniversity of California, San Francisco · US

Funding

HIV FITNESS, VIRULENCE AND EVOLUTIONR01CA086814 · NCI · J. DAVID GLADSTONE INSTITUTES · PI GREENE, WARNER C · 2000 to 2003
$1.1M
HIV CORECEPTORS--FUNCTION, SPECIFICITY AND PATHOGENESISR01AI043695 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI GOLDSMITH, MARK A · 1999 to 2001
$570k
NCI NIH HHS CA86814NIAID NIH HHS AI43695
6 · The paper itself

Abstract

The destruction of the immune system by progressive loss of CD4 T cells is the hallmark of AIDS. CCR5-dependent (R5) human immunodeficiency virus type 1 (HIV-1) isolates predominate in the early, asymptomatic stages of HIV-1 infection, while CXCR4-dependent (X4) isolates typically emerge at later stages, frequently coinciding with a rapid decline in CD4 T cells. Lymphocyte killing in vivo primarily occurs through apoptosis, but the importance of apoptosis of HIV-1-infected cells relative to apoptosis of uninfected bystander cells is controversial. Here we show that in human lymphoid tissues ex vivo, apoptosis of uninfected bystander CD4 T cells is a major mechanism of lymphocyte depletion caused by X4 HIV-1 strains but is only a minor mechanism of depletion by R5 strains. Further, X4 HIV-1-induced bystander apoptosis requires the interaction of the viral envelope glycoprotein gp120 with the CXCR4 coreceptor on CD4 T cells. These results emphasize the contribution of bystander apoptosis to HIV-1 cytotoxicity and suggest that in association with a coreceptor switch in HIV disease, T-cell killing evolves from an infection-restricted stage to generalized toxicity that involves a high degree of bystander apoptosis.

Indexed as

ApoptosisBystander EffectEvolution, MolecularCD3 ComplexCD4-Positive T-LymphocytesCells, CulturedHIV-1HIV InfectionsHumansPalatine TonsilReceptors, CXCR4VirulenceCD3 ComplexReceptors, CXCR4

Identifiers

PMID12719578
PMCPMC154038
OpenAlexW2148200221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.